Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSX Corporation (CSX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

CSX CorporationTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

CSX Corporation vs Zimmer Biomet Holdings Inc — how do they compare? CSX Corporation trades at $50.1 (market cap $92.55B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: CSX Corporation is far larger — about 5× Zimmer Biomet Holdings Inc's market cap, and CSX Corporation pays the higher dividend (1.12%). Which is the better fit depends on your goals.

CSXZBH
Market Cap
$92.55B$18.55B
Sector
IndustrialsHealth
52-Week High
$53.21$107.71
52-Week Low
$32.05$79.58
Enterprise Value
$110.52B$25.61B
Dividend Yield
1.12%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CSX Corporation

CSX trades at $50.12, down 0.3% on the day, with a neutral technical signal. Recent Q2 2026 earnings beat estimates with EPS of $0.54 versus $0.518 expected, driven by 10% revenue growth and margin expansion. The stock's valuation ratios, including a P/E of 29.05 and P/S of 6.41, reflect a premium pricing relative to historical levels. Analyst consensus is bullish with a $52.57 price target, supported by 58.69% buy ratings.

The outlook for CSX is positive, with projected 2026 revenue growth and improved cash flow. Key opportunities include strong intermodal demand and operational efficiency gains. Risks involve competitive pressures, fuel cost volatility, and potential economic slowdowns affecting freight volumes. The stock's current level offers a moderate upside to the consensus target, balanced by elevated valuation multiples.

Zimmer Biomet Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH